EE05439B1 - Ketotifeeni sisaldav oftalmiline ravimkoostis - Google Patents

Ketotifeeni sisaldav oftalmiline ravimkoostis

Info

Publication number
EE05439B1
EE05439B1 EEP200200040A EEP200200040A EE05439B1 EE 05439 B1 EE05439 B1 EE 05439B1 EE P200200040 A EEP200200040 A EE P200200040A EE P200200040 A EEP200200040 A EE P200200040A EE 05439 B1 EE05439 B1 EE 05439B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
composition containing
ophthalmic pharmaceutical
containing ketotifen
ketotifen
Prior art date
Application number
EEP200200040A
Other languages
English (en)
Estonian (et)
Inventor
Johanna Adam Marcia
Fetz Andrea
Lajos Kis Gy�rgy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of EE200200040A publication Critical patent/EE200200040A/xx
Publication of EE05439B1 publication Critical patent/EE05439B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200200040A 1999-07-23 2000-07-21 Ketotifeeni sisaldav oftalmiline ravimkoostis EE05439B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99114508 1999-07-23
PCT/EP2000/007030 WO2001007049A2 (en) 1999-07-23 2000-07-21 Ophthalmic composition comprising ketotifen

Publications (2)

Publication Number Publication Date
EE200200040A EE200200040A (et) 2003-04-15
EE05439B1 true EE05439B1 (et) 2011-08-15

Family

ID=8238654

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200040A EE05439B1 (et) 1999-07-23 2000-07-21 Ketotifeeni sisaldav oftalmiline ravimkoostis

Country Status (20)

Country Link
US (2) US6777429B1 (cs)
EP (1) EP1198223A2 (cs)
JP (1) JP2003505419A (cs)
KR (1) KR20020012261A (cs)
CN (1) CN1358086A (cs)
BR (2) BRPI0017528B8 (cs)
CA (1) CA2377024A1 (cs)
CZ (1) CZ300614B6 (cs)
EE (1) EE05439B1 (cs)
HK (1) HK1046631A1 (cs)
HU (1) HU230738B1 (cs)
IL (1) IL146973A0 (cs)
MX (1) MXPA02000849A (cs)
NO (1) NO331228B1 (cs)
NZ (1) NZ516108A (cs)
PL (1) PL202496B1 (cs)
RU (1) RU2248789C2 (cs)
UA (1) UA74788C2 (cs)
WO (1) WO2001007049A2 (cs)
ZA (1) ZA200200425B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002345015A1 (en) * 2001-06-08 2002-12-23 Novartis Pharma Gmbh Ophthalmic once-a-day composition
AR034371A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
WO2004064817A1 (ja) * 2003-01-22 2004-08-05 Nichiban Co., Ltd. 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
CN101087607B (zh) * 2004-10-25 2010-07-28 博士伦公司 眼用组合物及使用其的方法
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
EP3753548A1 (en) 2006-06-16 2020-12-23 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations suitable for intravitreal administration
US8445437B2 (en) * 2006-07-27 2013-05-21 The Brigham And Women's Hospital, Inc. Treatment and prevention of cardiovascular disease using mast cell stabilizers
CN101541303A (zh) 2006-09-29 2009-09-23 庄臣及庄臣视力保护公司 用于治疗眼变态反应性的方法和眼科装置
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
CN101808642B (zh) * 2007-09-28 2012-05-02 布里格海姆妇女医院公司 肥大细胞稳定剂治疗肥胖症
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2408302A4 (en) * 2009-03-17 2012-08-15 Aciex Therapeutics Inc OPHTALMIC FORMULATIONS OF KTOTICENE AND METHODS OF USE
RU2549472C1 (ru) * 2013-12-26 2015-04-27 Илья Александрович Марков Фармацевтическая композиция в форме капель для профилактики и лечения аллергических заболеваний глаз
CN114712497B (zh) 2015-12-03 2024-03-22 雷杰纳荣制药公司 抗vegf剂在制备用于治疗新生血管性年龄相关性黄斑变性患者的药物中的用途
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
CN111450051B (zh) * 2020-04-21 2022-03-18 武汉贝参药业股份有限公司 一种富马酸酮替芬口服溶液的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62277323A (ja) 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
RU2003350C1 (ru) * 1991-03-01 1993-11-30 Институт иммунологии Способ лечени глюкокортикостероидзависимых атопических заболеваний
RU2007117C1 (ru) * 1992-03-20 1994-02-15 Юлия Михайловна Залесская Способ индивидуального подбора веществ для коррекции нарушений в организме
DE69327878T2 (de) * 1993-04-16 2000-06-15 Wakamoto Pharmaceutical Co., Ltd. Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis
JPH07324034A (ja) * 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤
JPH11189533A (ja) * 1997-12-25 1999-07-13 Taisho Pharmaceut Co Ltd 点眼薬
EP0938896A1 (en) 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent

Also Published As

Publication number Publication date
CA2377024A1 (en) 2001-02-01
EE200200040A (et) 2003-04-15
BRPI0017528A2 (pt) 2010-01-19
HUP0202243A3 (en) 2006-03-28
UA74788C2 (en) 2006-02-15
BR0012696A (pt) 2002-04-09
ZA200200425B (en) 2002-10-30
JP2003505419A (ja) 2003-02-12
BRPI0017528B8 (pt) 2021-05-25
IL146973A0 (en) 2002-08-14
CZ300614B6 (cs) 2009-07-01
HK1046631A1 (zh) 2003-01-24
KR20020012261A (ko) 2002-02-15
EP1198223A2 (en) 2002-04-24
CN1358086A (zh) 2002-07-10
US6774137B2 (en) 2004-08-10
HU230738B1 (hu) 2018-01-29
NO331228B1 (no) 2011-11-07
MXPA02000849A (es) 2002-07-30
PL202496B1 (pl) 2009-06-30
NO20020319L (no) 2002-01-21
WO2001007049A3 (en) 2001-03-29
RU2248789C2 (ru) 2005-03-27
CZ2002243A3 (cs) 2002-04-17
HUP0202243A2 (hu) 2002-12-28
PL352382A1 (en) 2003-08-25
US20020183359A1 (en) 2002-12-05
NZ516108A (en) 2004-04-30
WO2001007049A2 (en) 2001-02-01
US6777429B1 (en) 2004-08-17
BRPI0017528B1 (pt) 2017-06-13
NO20020319D0 (no) 2002-01-21

Similar Documents

Publication Publication Date Title
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20015175D0 (no) Farmasöytisk sammensetning
EE05439B1 (et) Ketotifeeni sisaldav oftalmiline ravimkoostis
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DK1052974T3 (da) Farmaceutisk sammensætning indeholdende epothilon
PT1242087E (pt) Composicoes farmaceuticas
ID27415A (id) Komposisi farmaseutik
DE60011487D1 (de) Ophthalmisches Gerät
FI20010683L (fi) Nateglinidiä sisältävä koostumus
DE60037203D1 (de) Medikamentenspender
DE60011853D1 (de) Injektionsspritze
NO20012915D0 (no) Ny farmasöytisk formulering
DK1395242T3 (da) Flydende farmaceutisk sammensætning
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
ID29262A (id) Komposisi farmasi
PT1086701E (pt) Composicao laxante contendo simeticone
ID27201A (id) Komposisi farmasi
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20015510L (no) Medikament for lokal påföring
NO20014926D0 (no) Farmasöytiske forbindelser
PT1239832E (pt) Composicoes farmaceuticas
NO20003786D0 (no) Oftalmisk sammensetning
ID30032A (id) Formulasi farmasi
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus